Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Semler Scientific, Inc. (SMLR)
|
Add to portfolio |
|
|
|
| Price: |
$90.10
| | Metrics |
| OS: |
6.86
|
M
| |
|
|
| Market cap: |
$618
|
M
| |
|
|
|
Net cash:
|
$52.6
|
M
| |
$7.68
|
per share
|
|
EV:
|
$565
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 56.7 | 53.0 | 38.6 | 32.8 | 21.5 | 12.5 | 7.4 | 7.0 |
| Revenue growth | 6.9% | 37.4% | 17.8% | 52.5% | 72.6% | 67.5% | 6.2% | 92.6% |
| Cost of goods sold | 9.1 | 6.1 | 3.4 | 3.7 | 2.7 | 2.6 | 1.9 | 2.8 |
| Gross profit | 47.6 | 46.9 | 35.2 | 29.1 | 18.8 | 9.9 | 5.6 | 4.2 |
| Gross margin | 84.0% | 88.5% | 91.3% | 88.8% | 87.4% | 79.5% | 74.8% | 59.3% |
| Sales and marketing | 17.7 | 14.4 | 9.9 | 9.0 | 7.2 | 5.1 | 3.8 | 6.3 |
| Research and development | | | | | | | | |
| General and administrative | 12.7 | 9.2 | 6.4 | 7.0 | 4.2 | 3.8 | 3.0 | 4.9 |
| EBIT | 17.2 | 19.4 | 16.0 | 10.7 | 5.3 | -0.9 | -2.2 | -8.4 |
| EBIT margin | 30.3% | 36.7% | 41.3% | 32.7% | 24.9% | -6.9% | -29.0% | -120.3% |
| Pre-tax income | 17.7 | 19.5 | 16.5 | 10.7 | 5.0 | -1.5 | -2.5 | -8.5 |
| Income taxes | 3.4 | 2.2 | 2.5 | -4.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 19.0% | 11.5% | 15.0% | | 0.5% | | | |
| Net income | 14.3 | 17.2 | 14.0 | 15.1 | 5.0 | -1.5 | -2.6 | -8.5 |
| Net margin | 25.3% | 32.5% | 36.3% | 46.0% | 23.3% | -12.1% | -34.4% | -121.4% |
| |
| Diluted EPS | $1.79 | $2.12 | $1.74 | $1.88 | $0.66 | ($0.28) | ($0.50) | ($1.72) |
| Shares outstanding (diluted) | 8.0 | 8.1 | 8.1 | 8.0 | 7.6 | 5.4 | 5.1 | 4.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|